Aroldo A. DARGÉL

docteur aroldo dargel médecin psychiatre directeur centre thérapeutique jour préventif hopital clinique bellevue meudon

Aroldo A. DARGÉL

Directeur du Centre Thérapeutique et Préventif de Jour (CTPJ): Troubles Bipolaires et Comorbidités Associées

Troubles bipolaires

01 41 14 41 26 

Directeur du Centre Thérapeutique et Préventif de Jour – CTPJ

Le travail du Dr. A. DARGÉL est dédié au développement et à la coordination du projet du Centre Thérapeutique et Préventif de Jour (CTPJ) afin d’offrir aux personnes souffrant de troubles bipolaires et leurs comorbidités associées des soins psychiatriques innovants et individualisés.

Docteur en Médecine

Internat en Médecine Interne et Réanimation

Master en Epidémiologie

Internat en Psychiatrie

Thèse de Science (PhD) en Psychiatrie

Postdoctoral en Psychiatrie et Neurosciences

Troubles Bipolaires

Troubles de l’humeur

Big data en psychiatrie

Technologies mobiles en santé mentale

Publications sélectionnées:

1.             Dargél AA, Godin O, Etain B., Hirakata V, Azorin JM, M’Bailara, Bellivier F, Leboyer M, Henry C. Emotional reactivity, functioning, and C-reactive protein alterations in remitted bipolar patients: clinical relevance of a dimensional approach. Aust N Z J Psychiatry. Apr 2017 DOI: 10.1177/00048667417691850

2.             Ayub Dargél A, Masson M and Henry C. The RANZCP guidelines: Managing mood disorders in the real world. The Australian and New Zealand Journal of Psychiatry. 2016 Dec;50(12):1198-1199. DOI: 10.1177/0004867416676373

3.             Dargél AA, Godin O, kapczinski F, Kupfer D, Leboyer M. C-reactive protein alterations in bipolar disorder: a meta-analysis.J Clin Psychiatry. 2015;76(2):142-50. doi:10.4088/JCP.14r09007.

4.             Dargél AA & Leboyer M. Biomarkers in illness progression in bipolar disorder. Neuroprogression and Staging in Bipolar Disorder. 2015, Chapter 10. Oxford University Press. ISBN: 9780198709992.

5.             Henry C, Etain C, Godin O, Dargél AA, Azorin JM, Gard S, Bellivier F, Bougerol T, Kahn1 JP, Passerieux C, Aubin V, Courtet P, Leboyer M. Bipolar patients referred to specialized services of care: not resistant but impaired by subsyndromal symptoms: results from FACE-BD cohort. Aust N Z J Psychiatry. 2015 May 19 (ahead of print). pii: 0004867415585582.

6.             Etain B, Lajnef M, Henrion A, Dargél AA, Stertz S, Kapczinski F, Mathieu F, Henry C, Gard S, Khan JP, Leboyer M, Bellivier F. Interaction between SLC6A4 promoter variants and childhood trauma on the age at onset of bipolar disorders. Scientific Reports. 2015 Aug, accepted. SREP-15-22137.

7.             Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargél A, Oliveira J, Le Guen E, Marlinge E, Tamouza R, Leboyer M. Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand: 2014; 129: 163-179. doi: 10.1111/acps.12211.

8.             Fond G, Loundou A, Hamdani N, Boukouaci W, Dargél A, Roger M, Tamouza R, Leboyer M, Boyer L. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014; 264(8): 651-660. doi: 10.1007/s00406-014-0502-z.

9.          Fond G, Loundou A, Hamdani N, Boukaci W, Dargél A, Roger M, Tamouza R, Leboyer M, Boyer L. The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: a systematic review. Pathologie Biologie, 2015; 63(1): 35-42. doi: 10.1016/j.patbio.2014.10.003.

10.          Oliveira J, Busson M, Etain B, Jamain S, Dargél AA, Hamdani N, Leboyer M, Tamouza R. Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J Affect Disord. 2014; 152-154:395-402. doi: 10.1016/j.jad.2013.09.043.

11.          Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargél AA, Kunz M, Kapczinski F. Staging and Neuroprogression in Bipolar Disorder. Curr Psychiatry Rep. 2012 14:667-75; doi: 10.1007/s11920-012-0319-2.

12.          Thomé E, Dargél AA, Migliavaca FM, Kapczinski F, Cereser KM. Stigma experiences in bipolar patients: the impact upon overall and specific areas of functioning. J Psychiatric Mental Health Nurs. 2011; Nov 17: 1-7. doi: 10.1111/j.1365-2850.2011.01849.x.

13.          Vasconcelos-Moreno MP, Dargél AA, Goi PD, Bragatti JA, Kapczinski F, Kauer-Sant’Anna M. Effect of mood stabilizers on improvement of behavioural and manic-like symptoms secondary to herpes simplex encephalitis: a case report. Int J Neuropsychopharmacology. 2011 14:718-20. doi: 10.1017/S1461145710001598.

14.          Spanemberg L, Noguera E, Da Silva CTB, Dargél AA, Menezes FS, Cataldo A et al. High prevalence and prescription of benzodiazepines for elderly. Gen Hosp Psychiatry. 2011; V.33: 45-50. doi: 10.1016/j.genhosppsych.2010.12.004.

 

Français

Anglais

Espagnol

Portugais

Arij BENNOUR